Literature DB >> 14997014

Adrenergic activation of steroid 5alpha-reductase gene expression in rat C6 glioma cells: involvement of cyclic amp/protein kinase A-mediated signaling pathway.

Kyoji Morita1, Hideki Arimochi, Yoshihiro Tsuruo.   

Abstract

Steroid 5alpha-reductase (5alpha-R) is well known as the enzyme converting progesterone and other steroid hormones to their 5alpha-reduced metabolites and has been reported to be localized in both neuronal and glial cells in the brain. Previously, the enzyme activity in glial cells has been shown to be enhanced either by coculturing with neuronal cells or by adding the conditioned medium of neuronal cells, suggesting a possible implication of neuro-glial interactions in the regulation of neurosteroid metabolism in the brain. In the present studies, the effects of adrenergic agonists on 5alpha-R mRNA and protein levels in rat C6 glioma cells were examined as one of the model experiments for investigating the influence of neuronal activity on the expression of 5alpha-R gene in the glial cell. The direct challenge of beta-adrenergic agonists to glioma cells resulted in the rapid and transient elevation of 5alpha-R mRNA levels through the activation of the cyclic AMP (cAMP)/protein kinase A-mediated signaling pathway. Further studies showed that cAMP-induced 5alpha-R mRNA expression was completely abolished by pretreatment of cells with actinomycin D and also indicated that the elevation of 5alpha-R mRNA levels was accompanied by an increase in enzyme protein in the cells. These findings provide strong evidence that the stimulation of beta-adrenergic receptors might induce the transcriptional activation of 5alpha-R gene expression in glial cells, proposing the possibility that neuronal activity might be involved in the production of neuroactive 5alpha-reduced steroids in the brain.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14997014     DOI: 10.1385/JMN:22:3:205

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  11 in total

1.  Influence of serum-free culture conditions on steroid 5alpha-reductase mRNA expression in rat C6 glioma cells.

Authors:  K Morita; Y Tsuruo; K Ishimura; S Her; R A Bell; D L Wong
Journal:  Brain Res       Date:  1999-05-29       Impact factor: 3.252

2.  Brain 5alpha-reductase: cellular, enzymatic, and molecular perspectives and implications for biological function.

Authors:  E D Lephart
Journal:  Mol Cell Neurosci       Date:  1993-12       Impact factor: 4.314

3.  Cyclic AMP-mediated induction of the glial fibrillary acidic protein is independent of protein kinase A activation in rat C6 glioma.

Authors:  K Anciaux; K Van Dommelen; S Nicolai; E Van Mechelen; H Slegers
Journal:  J Neurosci Res       Date:  1997-05-15       Impact factor: 4.164

4.  Phenylethanolamine N-methyltransferase mRNA in rat hypothalamus and cerebellum.

Authors:  J L Andreassi; W B Eggleston; G Fu; J K Stewart
Journal:  Brain Res       Date:  1998-01-01       Impact factor: 3.252

5.  Progesterone 5-alpha-reduction in neuronal and in different types of glial cell cultures: type 1 and 2 astrocytes and oligodendrocytes.

Authors:  R C Melcangi; F Celotti; L Martini
Journal:  Brain Res       Date:  1994-03-14       Impact factor: 3.252

6.  Tissue distribution and kinetic characteristics of rat steroid 5 alpha-reductase isozymes. Evidence for distinct physiological functions.

Authors:  K Normington; D W Russell
Journal:  J Biol Chem       Date:  1992-09-25       Impact factor: 5.157

7.  Immunocytochemical localization of 5 alpha-reductase type 1 in the prostate of normal and castrated rats.

Authors:  T Miyamoto; S Kagawa; K Kitagawa; S Futaki; H Yokoi; Y Tsuruo; K Ishimura
Journal:  Histochem Cell Biol       Date:  1996-02       Impact factor: 4.304

8.  Differential localization of the 5 alpha-reductase and the 3 alpha-hydroxysteroid dehydrogenase in neuronal and glial cultures.

Authors:  R C Melcangi; F Celotti; P Castano; L Martini
Journal:  Endocrinology       Date:  1993-03       Impact factor: 4.736

9.  Intracellular signalling systems controlling the 5 alpha-reductase in glial cell cultures.

Authors:  R C Melcangi; F Celotti; P Castano; L Martini
Journal:  Brain Res       Date:  1992-07-10       Impact factor: 3.252

10.  Crosstalk between normal and tumoral brain cells. Effect on sex steroid metabolism.

Authors:  R C Melcangi; I Cavarretta; V Magnaghi; M Ballabio; L Martini; M Motta
Journal:  Endocrine       Date:  1998-02       Impact factor: 3.633

View more
  6 in total

1.  5α-reductase 1 regulates spinal cord testosterone after morphine administration.

Authors:  Alireza Sharif; Alireza Shoae-Hassani; Shiva Sharif; Hamid Reza Banafshe; Seyed Abdolreza Mortazavi-Tabatabaei; Javad Verdi
Journal:  Neurol Sci       Date:  2012-01-19       Impact factor: 3.307

Review 2.  The relevance of neuroactive steroids in schizophrenia, depression, and anxiety disorders.

Authors:  Erin M MacKenzie; John Odontiadis; Jean-Michel Le Mellédo; Trevor I Prior; Glen B I Baker
Journal:  Cell Mol Neurobiol       Date:  2007-08       Impact factor: 5.046

3.  Progesterone pretreatment enhances serotonin-stimulated BDNF gene expression in rat c6 glioma cells through production of 5alpha-reduced neurosteroids.

Authors:  Kyoji Morita; Song Her
Journal:  J Mol Neurosci       Date:  2008-01-25       Impact factor: 3.444

4.  Trichostatin A stimulates steroid 5alpha-reductase gene expression in rat C6 glioma cells via a mechanism involving Sp1 and Sp3 transcription factors.

Authors:  Song Her; Mi-Sook Lee; Kyoji Morita
Journal:  J Mol Neurosci       Date:  2009-09-02       Impact factor: 3.444

Review 5.  Overview of the Molecular Steps in Steroidogenesis of the GABAergic Neurosteroids Allopregnanolone and Pregnanolone.

Authors:  Jennifer J Liang; Ann M Rasmusson
Journal:  Chronic Stress (Thousand Oaks)       Date:  2018-12-19

Review 6.  Biosynthesis and signalling functions of central and peripheral nervous system neurosteroids in health and disease.

Authors:  Emyr Lloyd-Evans; Helen Waller-Evans
Journal:  Essays Biochem       Date:  2020-09-23       Impact factor: 8.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.